Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-01-06 @ 3:06 PM
Study NCT ID:
NCT06489860
Status:
WITHDRAWN
Last Update Posted:
2025-09-04
First Post:
2024-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SARS-CoV-2 Safety Study for the Treatment of COVID-19
Sponsor:
DHA Coffee Co., Ltd
Organization:
Study Overview
Official Title:
SARS-CoV-2 Safety Study for the Treatment of COVID-19
Status:
WITHDRAWN
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
My record is not overseen by an IRB, I change the Overall Status to Withdrawn.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SARS-CoV-2
Brief Summary:
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to protect Telomere chromosomes to maintain Acid Deoxyribonucleic (ADN) Molecules.
Detailed Description:
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to change and disappear defective cells in virus variants, Covid-19 disease. Pluripotent stem cells produced strong cells serve as a repair system, replacing damaged cells, defective cells and dead cells.
CHEMISTRY:
SARS-CoV-2 does not use any chemicals, no colors and no additives and no preservatives.
Toxicology:
SARS-CoV-2 product is not adverse effect, non-toxic and no pharmacal toxicology.
SARS-CoV-2 is not placebo drug
CHEMISTRY:
SARS-CoV-2 does not use any chemicals, no colors and no additives and no preservatives.
Toxicology:
SARS-CoV-2 product is not adverse effect, non-toxic and no pharmacal toxicology.
SARS-CoV-2 is not placebo drug
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: